Literature DB >> 14598106

Development of a new extracorporeal whole-liver perfusion system.

Katsutoshi Naruse1, Yasuyuki Sakai, Lei Guo, Takeshi Natori, Junichi Shindoh, Yasuaki Karasawa, Yuhki Iida, Kentaro Kojima, Kazuya Michishita, Masatoshi Makuuchi.   

Abstract

We have developed a new extracorporeal whole-liver accommodation device in which a whole swine liver is placed in a physiological state by modeling the intraabdominal arrangement in the pig body, with the liver supported by a special inferior vena cava tube. Furthermore, we employed a diaphragm-type artificial heart in our system to produce pulsatile blood flow through the hepatic artery, which is considered to be indispensable to dilate peripheral vessels and supply oxygenated whole blood to the peripheral liver tissue. Beneficial effects were demonstrated in visual findings and bile juice secretion. The color of the liver surface in our system remained bright red, indicating that the liver vessels were well drained and free from congestion, and bile juice secretion was maintained at more than 10 ml/h throughout the perfusion period. Our system exhibited excellent ammonia removal and urea nitrogen synthesis, and serum aspartate aminotransferase levels showed no increase, indicating the absence of hepatocyte destruction. Histological findings showed that the liver could expand appropriately and was free from compression caused by its own weight. In conclusion, our original liver accommodation device enabled appropriate expansion of the whole liver and supplied adequate oxygenated blood to peripheral areas by means of a pulsatile pump.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598106     DOI: 10.1007/s10047-003-0225-9

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  6 in total

Review 1.  Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.

Authors:  Katsutoshi Naruse; Wei Tang; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

2.  Preservation of non-heart-beating donor livers in extracorporeal liver perfusion and histidine-trytophan-ketoglutarate solution.

Authors:  Jin Gong; Xue-Jun Lao; Xi-Mo Wang; Gang Long; Tao Jiang; Shi Chen
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

3.  Development and perspectives of perfusion treatment for liver failure.

Authors:  Katsutoshi Naruse; Hiroshi Nagashima; Yasuyuki Sakai; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 4.  Artificial liver support at present and in the future.

Authors:  Kazuhiko Onodera; Hiromi Sakata; Motoki Yonekawa; Akio Kawamura
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

5.  New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.

Authors:  Luiz Anastácio Alves; André Bonavita; Kátia Quaresma; Elenilde Torres; Paulo Anastácio Furtado Pacheco; Vinícius Cotta-de-Almeida; Roberto Magalhães Saraiva
Journal:  Cell Med       Date:  2010-07-01

6.  Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes.

Authors:  Joanne L Zahorsky-Reeves; Clare R Gregory; Donald V Cramer; Insiyyah Y Patanwala; Andrew E Kyles; Dominic C Borie; Mary K Kearns-Jonker
Journal:  BMC Immunol       Date:  2006-03-20       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.